Tristel Share Discussion Threads

[petersinthemarket] 16/11/2017 11:23

Tks guys. This is currently one of Mrs P's cautious long term holdings. We have no problems with the company and its products and she is ok with a fairly stable sp, although some capital appreciation would obviously be nice.
The main aim in her pf is for total return to comfortably beat bank savings. So we are typically looking for a stable or better share price and a good and appreciating div which is around twice or better than she can get with a bank.
We fully understand the words Special Dividend, but the loss of it brings her potential yield down close to 2% and we think we can do better elsewhere.
FWIW, her other holdings at the moment (IBST, JIM, LGEN, PCTN, RGL, STOB, WJG) are yielding between 4 and 7.5%. We haven't yet decided what to do and I will let her instinct decide in the end, but mny tks for the pointers. pete

[melton john] 15/11/2017 15:07

Pete, I will take up your challenge to point out what you may have missed.
It's a year last August when I saw the light with TSTL, made a small investment and made several more as cash became available. Apad first mentioned it, for which I'm grateful, but I did lots of independent research before I invested and you may like to fill in any gaps in what you know about TSTL by going back to read some of it along with posts by others around that time. I don't have the time to do research to that level any more but it's still very relevant. I'm quite happy to forego some dividend income with this company as I can see where it will be in the future. Please go back and read up from the point it began to dawn on me and I'm sure you and other family members will get it and be patient.

[piedro] 15/11/2017 09:10

PITM,
There is nothing esoteric about the dividend policy ...

... all was well till they hit trouble in 2010-11 when they were obliged to reduce.
With the recovery in 2014 dividends once again resumed their growth and now in 2017 are back to normal.

The 2 specials can perhaps be considered as compensation for the shortfall of 2011-13

AIMHO

[petersinthemarket] 14/11/2017 17:49

The share price has certainly been volatile. Doesn't matter much for LTH's but there has also been a substantial share price fall and an equally large fall in yield due to the lack of a special dividend, This may be putting some people off. We bt for yld with the hope of an improvement so we will consider a sale. I am sure someone will put me right if I've missed something.

[piedro] 14/11/2017 14:14

someone cashing in ...

Issue of Equity
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, following the exercise of options by an employee, it has issued and allotted 116,950 new ordinary shares of 1 penny each in the Company

[piedro] 14/11/2017 13:57

I get the impression that Tristel has lost interest in Anistel,
no promotions having been seen for some time, whereas their rival
and 'ex-source' company, Medimark Scientific, can be found in most
of the veterinary shows



AIMHO

[richhead] 14/11/2017 13:38

Tristel has always been volatile. It is true that PE is high but the potential for future growth in the USA is very strong and could be a game changer. Of course there are risks but so far the company has always delivered.

[james188] 13/11/2017 21:23

I very much doubt that the fall in the share price today was down to the article by Richard Beddard referenced above. In essence, it was a well written article which simply questioned whether too much future profit growth was being assumed in the share price as at the end of last week. It is less than 3 weeks ago that I bought a slug of these shares at 268p - and that was by a large distance the most I have ever paid for this share. I expect that the price will continue to bounce around. As I am still adding, I fervently hope so.

[piedro] 13/11/2017 19:31

mdr26niz,
Can you give us the link? Please

[mdr26nlz] 13/11/2017 18:51

Look for the article in the iii from yesterday!

[zimbtrader] 13/11/2017 17:09

No clues, Trapper. I sold 2500 at 297 and find myself pretty tempted to buy them back... maybe my sale triggered the drop? ;-)

[trapperjez] 13/11/2017 16:16

Why the big share price drop today?

[briangeeee] 07/11/2017 23:06

murray80, I understand and agree that any sale would require shareholder approval. However, after the last debacle, the board should be going the extra mile. If they're confident that there won't be a sale at a lower valuation than the performance targets, then let's make the performance conditions apply equally in both situations. Why not?

You comment about it being normal for options to vest on takeover. Well perhaps, but the point is that normal options are not NIL COST. That makes all the difference. With "normal" options, directors are rewarded for an uplift in share price. With NIL COST, they may well be rewarded for a reduction in share price.

Surely it's very simply to change the scheme, and more importantly, the right thing to do.

[piedro] 07/11/2017 12:51

Tristel Global‏ @TristelGlobal
See Crystel range at NHS Pharmaceutical Quality
Assurance & Technical Services Symposium 2017
in Chester until tomorrow! #NHSQA #cleanroom

[murray80] 07/11/2017 08:15

Briangee - "if a bid is proposed" don't forget that a company sale would need a substantial majority in a shareholder vote. It's not just down to the Board. The Board are also the largest shareholders so I don't see why they would sell at a low price against theirs and everyone else's best interests. I also know that almost all company option schemes become exercisable if a company is sold.

[piedro] 03/11/2017 12:04

Tristel Global‏ @TristelGlobal
Showcasing #Stella at the Chinese Urology Association
AGM! #ontheroad #cystoscopes #disinfection #infectioncontrol

[supernumerary] 03/11/2017 09:56

These vesting clauses are pretty standard. Even when there isn't such a clause, options normally vest on change of control - the buyer just makes it part of the offer - because it's a relatively cheap way for the buyer to get the board onside. Not much better than a bribe in my view, and it should be treated as such, but that's the way it is.

Not as bad as those boards who get their bonuses for making an acquisition, another pernicious but common practice.

[zimbtrader] 03/11/2017 07:54

I'm happy with the options proposed with one very major objection - "In the event of a change of control of the Company all options will vest."

I agree with Peidro and Braingeeee... How on earth does that support shareholders interests with respect to imposing some control over what the board does in the event of a "stupid offer" being put forward? If this is the proposal as it stands, I seriously hope it is rejected.

[piedro] 02/11/2017 15:01

FWIW,

Existing reprocessing techniques prove insufficient for flexible endoscopes
Arlington, VA, January 31, 2017 – Current techniques used to clean endoscopes for reuse are not consistently effective, according to a study published in the February issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology (APIC). The findings of this study support the need for careful visual inspection and cleaning verification tests to ensure that all endoscopes are free of damage and debris before they are high-level disinfected or sterilized and used on another patient. ... ...

[briangeeee] 02/11/2017 10:39

If there is a bid for the company at £1.40 per share, which is recommended and proceeds, will management be rewarded for that?

Is that the correct way to structure such a scheme, and align interests?

[piedro] 02/11/2017 10:24

New Share Option Scheme

The 2018 Scheme
The 2018 Scheme will be put forward for approval by shareholders at the Company's Annual General Meeting. If the 2018 Scheme is approved 990,000 share options will be granted on 1 January 2018 as follows:

· Paul Swinney 500,000 options;
· Elizabeth Dixon 400,000 options;
· Paul Barnes 45,000 options;
· David Orr 45,000 options.

The options will be exercisable at 1 penny per share and will vest in three equal tranches as follows:

· One-third will vest upon the achievement of a share price of £3.50;
· One-third will vest upon the achievement of a share price of £4.25;
· One-third will vest upon the achievement of a share price of £5.00.

To vest, the average share price of Tristel plc must be above the hurdle rate for a minimum three-month period

In the event of a change of control of the Company all options will vest. Any vested but unexercised options will expire on 30 June 2021. As an additional condition, the options will only be exercisable if the holder commits to hold the resulting ordinary shares until 30 June 2021 or, if sooner, until a change of control of the Company occurs.

- I would prefer @ £4.50, £6.00 and £7.50
- and do not enjoy the talk of change of control
- a change of CEO and Chairman, yes

AIMHO

[melton john] 23/10/2017 09:52

Talk of "Post antibiotic armageddon" on the news must mean more reliance on old fashioned hygiene and antiseptics for the future.

[zimbtrader] 21/10/2017 09:07

The presentation pack is now available at

Unfortunately, the company did not record a webinar, so this is all we have beyond comments from those who managed to attend (my thanks to them).

[piedro] 20/10/2017 14:51

Newmarket-based Tristel tops market expectations for annual sales and profits
PUBLISHED: 19 October 2017
Duncan Brodie

[zimbtrader] 20/10/2017 11:58

I've e-mail Walbrook PR to request that they ensure the results presentation pack and (if available) a webinar of the results presentation is published ASAP on the company website. Hopefully they will deliver and provide us with something to digest over the weekend.

A tad disappointed by today's drop but not completely surprised. I'm in for the long haul so not unduly worried...